Insights

Acceliant Transforms one of the largest eClinical Studies

A Fortune 500 pharmaceuticals company sought an EDC solution for a late phase immunology and infectious disease target audience. Acceliant developed a scalable platform to address the quantum of data as the trial progressed.

07 Jul 2017

Lupin Implements Acceliant Platform for BA/BE studies

Acceliant developed a robust platform with a best-of-breed interface for clinical studies of Lupin.

07 Jul 2017